AZN

How is AZN doing right now?

In plain terms: AZN is 15.1% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

AstraZeneca plc (AZN) sits 15.1% off its peak and is currently in a moderate correction, last printing at $13,200. A drawdown of this depth is where patient buyers start paying attention. Historically the asymmetry begins to favor accumulation here, especially when paired with structural demand.

What history says at this drawdown

AZN reaches this drawdown band repeatedly in its history (1179 observations), which is a large sample for the segmentation engine to compute a stable median forward return. The engine uses a rolling 90-day window and gives more weight to recent years — this lets the signal adapt to regime changes (e.g., post-COVID volatility) without losing the long-run base rate.

What this means for AZN

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to AZN's own volatility history. Moderate corrections are the highest-information zone for the Dipsern signal: enough drawdown for mean-reversion to matter, not so much that fundamentals are likely broken. Watch the prediction-error column — if past signals at this level were accurate, the current one is more trustworthy.